Open AccessTreatment of Helicobacter Pyori – an Overview of Current Strategies of Diagnostic and Treatment
Author(s) -
Ruxandra BABIUC,
Raluca Ionescu,
Lucian Negreanu
Publication year - 2021
Publication title -
modern medicine
Language(s) - English
Resource type - Journals
eISSN - 2360-2473
pISSN - 1223-0472
DOI - 10.31689/rmm.2021.28.3.263
Subject(s) - medicine , helicobacter pylori , disease , gastritis , cancer , lymphoma , malt lymphoma , atrophic gastritis , gastroenterology , population , helicobacter pylori infection , intensive care medicine , environmental health
Helicobacter Pylori infection, responsible for ulcerous disease, atrophic gastritis,gastric cancer and MALT lymphoma (mucosa-associated lymphoid tissue) has a very high prevalence in the general population (approximately 50%). In Romania there are few data related to the prevalence of Helicobacter Pylori infection, as well as the resistance to antibiotic treatment, and the methods of patient surveillance are limited by costs and low accessibility. The aim of our paper is to recall the current possibilities of treatment and supervision of this category of patients, taking into account that the appropiate treatment and good monitoring of the patient can cure the complications of the disease and may prevent the occurrence of malignancies.